The First FDA-Approved Digital Pill — What It Means For Pharma Harsha Madannavar Justin Wang Helen Chen Read more
Related Practice Life Sciences & Pharma In mid-November 2017, the U.S. FDA approved Japan-based Otsuka Pharmaceutical’s Abilify MyCite— a first for digital medicine. 07312019140709
Article Life Sciences & Pharma Impact of the US BIOSECURE Act on Biopharmas, Contract Services and Investors July 2, 2024
Case Study Biotech and Pharmaceuticals Reimbursement Assessment for a Therapy for Hemodialysis Patients May 3, 2024 A biopharmaceutical company with a novel treatment of chronic kidney disease-associated pruritus asked L.E.K. to assess the potential risk of bundling of…
Article Mental and Behavioral Health Exploring the Psychedelics Landscape: Looking Ahead to Funding in 2024 February 20, 2024
Executive Insights Biotech and Pharmaceuticals Variability in Large Pharma Launch Performance January 16, 2024